State GA
Clinical Trials in Georgia
Recruiting clinical trials with at least one study location in Georgia. Data updated daily from ClinicalTrials.gov.
Top Conditions in Georgia
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT05076175 Phase 2, Phase 3
Recruiting
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Mod...
Condition
Colitis, Ulcerative
Enrollment
120 pts
Location
United States, Australia, Belgium
Sponsor
Bristol-Myers Squibb
NCT06961370 Phase 1
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodyna...
Condition
Geographic Atrophy
Enrollment
132 pts
Location
United States
Sponsor
Hoffmann-La Roche
NCT06897475 Phase 2
Recruiting
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes ...
Condition
Type 2 Diabetes
Enrollment
240 pts
Location
United States, Canada, Germany
Sponsor
Eli Lilly and Company
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06660654 Phase 2
Recruiting
A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid...
Condition
Advanced Solid Tumor
Enrollment
200 pts
Location
United States, Belgium, China
Sponsor
Daiichi Sankyo
NCT04038502 Phase 2
Recruiting
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Condition
Metastatic Castrate Resistant Prostate Cancer
Enrollment
100 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT05826457 N/A
Recruiting
North American Prodromal Synucleinopathy Consortium Stage 2
Condition
REM Sleep Behavior Disorder
Enrollment
500 pts
Location
United States, Canada
Sponsor
Washington University School o
NCT05112601 Phase 2
Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System...
Condition
Endometrial Adenocarcinoma
Enrollment
81 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT03127631 N/A
Recruiting
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prost...
Condition
Prostate Cancer
Enrollment
6,000 pts
Location
United States, Australia, Brazil
Sponsor
McMaster University
NCT05304767 Phase 3
Recruiting
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive Kar...
Condition
Schizophrenia
Enrollment
280 pts
Location
United States, Bulgaria, Czechia
Sponsor
Karuna Therapeutics, Inc., a B
NCT06760507 N/A
Recruiting
Evaluating an Evidence-Based Family History Screening Program Adapted to Increas...
Condition
Breast Cancer
Enrollment
3,209 pts
Location
United States
Sponsor
Emory University
NCT04077762 N/A
Recruiting
Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complica...
Condition
Patient Satisfaction
Enrollment
3,266 pts
Location
United States
Sponsor
Minneapolis Heart Institute Fo
NCT03779854 Phase 2
Recruiting
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Child...
Condition
Acute Biphenotypic Leukemia
Enrollment
68 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT06414954 Phase 2
Recruiting
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia...
Condition
Myasthenia Gravis
Enrollment
84 pts
Location
United States, Belgium, Denmark
Sponsor
NMD Pharma A/S
NCT03611595 Phase 1
Recruiting
Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed ...
Condition
Solid Tumor
Enrollment
18 pts
Location
United States
Sponsor
Peter Zage
NCT07018700 Phase 3
Recruiting
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preve...
Condition
Episodic Migraine
Enrollment
990 pts
Location
United States, Austria, Czechia
Sponsor
Merz Therapeutics GmbH
NCT05642572 Phase 2
Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
66 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT06058039 Phase 3
Recruiting
Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depre...
Condition
Major Depressive Disorder
Enrollment
332 pts
Location
United States, Bulgaria, Czechia
Sponsor
Neumora Therapeutics, Inc.
NCT07195695 Phase 3
Recruiting
Beamion LUNG-3: A Study to Test Whether Zongertinib Helps People With Surgically...
Condition
Non-small Cell Lung Cancer
Enrollment
400 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT07061964 Phase 2
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Rem...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
111 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06378632 N/A
Recruiting
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE ...
Condition
Heart Failure
Enrollment
500 pts
Location
United States, Israel, Spain
Sponsor
Cordio Medical
NCT04284436 N/A
Recruiting
Study in Parkinson Disease of Exercise
Condition
Parkinson Disease
Enrollment
370 pts
Location
United States, Canada
Sponsor
Northwestern University